title: [Clearance of anti-cancer agent in hepatic carcinoma after transarterial embolization with lipiodol assessed by Tc-99m pertechnetate].
authors.forename: H
authors.initials: H
authors.lastname: Yoshimura
authors.forename: K
authors.initials: K
authors.lastname: Iwata
authors.forename: K
authors.initials: K
authors.lastname: Ide
authors.forename: S
authors.initials: S
authors.lastname: Tsutsui
authors.forename: S
authors.initials: S
authors.lastname: Hamada
authors.forename: K
authors.initials: K
authors.lastname: Yoshiya
authors.forename: J
authors.initials: J
authors.lastname: Tsushima
authors.forename: F
authors.initials: F
authors.lastname: Nakagawa
authors.forename: H
authors.initials: H
authors.lastname: Sakaguchi
authors.forename: T
authors.initials: T
authors.lastname: Yoshioka
mesh_terms: D000970:Antineoplastic Agents / Q000378:metabolism*; D006528:Carcinoma, Hepatocellular / Q000378:metabolism* / Q000628:therapy; D004317:Doxorubicin / Q000378:metabolism; D004621:Embolization, Therapeutic / Q000379:methods*; D006801:Humans; D007459:Iodized Oil / Q000008:administration & dosage* / Q000378:metabolism; D008113:Liver Neoplasms / Q000378:metabolism* / Q000628:therapy; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D013670:Sodium Pertechnetate Tc 99m / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D007459:Iodized Oil; D004317:Doxorubicin; D013670:Sodium Pertechnetate Tc 99m